Status:
COMPLETED
Allogeneic Cell Therapy for Adults With Hematologic Malignancies
Lead Sponsor:
Emory University
Conditions:
Hematologic Diseases
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This is a research study involving the treatment of leukemia or lymphoma (lymph gland cancer) in adults who have leukemia or lymphoma that is unlikely to be cured with regular anticancer drugs or radi...
Detailed Description
This is a research study involving the treatment of leukemia or lymphoma (lymph gland cancer) in adults who have leukemia or lymphoma that is unlikely to be cured with regular anticancer drugs or radi...
Eligibility Criteria
Inclusion
- To be eligible as a recipient for this study, patients must have chronic myelocytic leukemia (CML) in chronic phase and be older than 60 years of age, have advanced myelodysplastic syndrome (MDS) and be over 60 years of age, have chronic lymphocytic leukemia (CLL) and be over 50 years of age, or have low grade lymphoma and be over 50 years of age. HLA typing of the recipient's family will be used to identify potential donors. Please contact study nurse for additional eligibility criteria. Final eligibility will be determined by the health professionals conducting this clinical trial.
Exclusion
- Patients with an active, invasive/systemic fungal infection and patients with serologic evidence of antibodies to HIV I/II will be excluded from participating as recipients in this study. Additional exclusion factors include: patients who are pregnant or lactating, those with active central nervous system (CNS) malignant disease, and patients whose life expectancy is limited by diseases other than the disease for which the transplant is being performed. Please contact study nurse for additional ineligibility criteria. Final eligibility will be determined by the health professionals conducting this clinical trial.
Key Trial Info
Start Date :
September 1 1998
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00208962
Start Date
September 1 1998
End Date
August 1 2013
Last Update
August 12 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University Winship Cancer Institute
Atlanta, Georgia, United States, 30322